Treatment of PCa cells with DZNeP (EZH2 inhibitor) resulted in an increase in TNIK protein expression as well as phosphorylation levels, while interestingly downregulating AR levels as well (Figure 3H). Here, EZH2 is linked to posterior cortical atrophy.